Exelixis reported $51.62M in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -15.3M 28.41M
Acceleron Pharma XLRN:US $ -70.63M 6.97M
Agios Pharmaceuticals AGIO:US $ -89.16M 0.07M
Akebia Therapeutics AKBA:US $ -54.89M 24.46M
Amgen AMGN:US $ 2378M 1550M
AstraZeneca AZN:LN -1674000000 2.8B
Bayer BAYN:GR 530M 2.81B
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Bristol Myers Squibb BMY:US $ 1996M 281M
Cytokinetics CYTK:US $ -69.2M 14.4M
Dicerna Pharmaceuticals DRNA:US $ -20.27M 19.97M
Eisai 4523:JP Y 5499M 49908M
Eli Lilly And LLY:US $ 1476M 72.6M
Esperion Therapeutics ESPR:US $ -55745000 23.21M
Exelixis EXEL:US $ 51.62M 71.39M
Genmab GEN:DC 890M 103M
Glaxosmithkline GSK:US $ 1938M 263M
Immunogen IMGN:US $ -34.23M 6.86M
IONIS PHARMACEUT IONS:US $ -86M 4.4M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Moderna Inc MRNA:US 3.56B 496M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Neurocrine Biosciences NBIX:US $ 44.5M 18.3M
Novartis NOVN:VX 3.23B 246M
Pfizer PFE:US $ 7647M 1733M
Puma Biotechnology PBYI:US $ -41.6M 39.87M
Seattle Genetics SGEN:US $ -297.96M 208.36M
Takeda 4502:JP Y 97427M 151125M
Ultragenyx Pharmaceutical RARE:US $ -89.83M 7.05M
Xencor XNCR:US $ -41.9M 50.99M
YTE INCY:US $ 235.41M 94.57M